500,000 Shares in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU) Bought by ADAR1 Capital Management LLC

ADAR1 Capital Management LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 500,000 shares of the company’s stock, valued at approximately $5,065,000. Oaktree Acquisition Corp. III Life Sciences accounts for approximately 1.0% of ADAR1 Capital Management LLC’s holdings, making the stock its 24th biggest holding.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Kepos Capital LP acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at approximately $709,000. Athos Capital Ltd acquired a new position in Oaktree Acquisition Corp. III Life Sciences in the 4th quarter worth $507,000. Finally, Rangeley Capital LLC acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 4th quarter valued at about $101,000.

Oaktree Acquisition Corp. III Life Sciences Stock Down 1.4 %

NASDAQ:OACCU opened at $10.27 on Monday. The stock’s 50-day moving average price is $10.23. Oaktree Acquisition Corp. III Life Sciences has a 52-week low of $9.99 and a 52-week high of $10.60.

About Oaktree Acquisition Corp. III Life Sciences

We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.